XML 33 R19.htm IDEA: XBRL DOCUMENT
v3.25.1

BUSINESS OPTIMIZATION CHARGES | 3 Months Ended
--- | ---
Mar. 31, 2025
Restructuring and Related Activities [Abstract] |
BUSINESS OPTIMIZATION CHARGES | BUSINESS OPTIMIZATION CHARGES In recent years, we have undertaken actions to transform our cost structure and enhance operational efficiency. These efforts include restructuring the organization into verticalized segments, optimizing the manufacturing footprint, R&D operations and supply chain network, employing disciplined cost management, and centralizing and streamlining certain support functions. We currently expect to incur additional pre-tax costs, primarily related to the implementation of business optimization programs, of approximately $4 million through the completion of initiatives that are currently underway. We continue to pursue cost savings initiatives, including those intended to mitigate a portion of the dis-synergies that arose as a result of the sale of our Kidney Care business, and to the extent further cost savings opportunities are identified, we would incur additional restructuring charges and costs to implement business optimization programs in future periods. For segment reporting, business optimization charges are unallocated expenses. During the three months ended March 31, 2025 and 2024, we recorded the following charges related to business optimization programs.
| Three Months Ended March 31, |  |
(in millions) | 2025 | 2024 |  |  |
Restructuring charges | $ | 44 |  | $ | 17 |  |  |  |
Costs to implement business optimization programs | 1 |  | 5 |  |  |  |
Total business optimization charges | $ | 45 |  | $ | 22 |  |  |  |
Costs to implement business optimization programs for the three months ended March 31, 2025 and 2024, respectively, consisted primarily of external consulting and transition costs, including employee compensation and related costs. These costs were primarily included within cost of sales and SG&A expense. During the three months ended March 31, 2025 and 2024, we recorded the following restructuring charges.
| Three months ended March 31, 2025
(in millions) | COGS | SG&A | R&D | Total
Employee termination costs | $ | 12 |  | $ | 13 |  | $ | 1 |  | $ | 26 |
Asset write offs | 1 |  | 17 |  | — |  | 18 |
Total restructuring charges | $ | 13 |  | $ | 30 |  | $ | 1 |  | $ | 44 |
| Three months ended March 31, 2024
(in millions) | COGS | SG&A |  | Total
Employee termination costs | $ | 3 |  | $ | 11 |  |  | $ | 14 |
Contract termination and other costs | — |  | 3 |  |  | 3 |
Total restructuring charges | $ | 3 |  | $ | 14 |  |  | $ | 17 |
For the three months ended March 31, 2025, $25 million of the restructuring charges reflected in the table above, consisting of employee termination costs, were related to initiatives to reduce our cost structure following the sale of our Kidney Care segment. For the three months ended March 31, 2024, $6 million of the restructuring charges reflected in the table above, consisting of employee termination costs, were related to the implementation of our operating model intended to streamline our operations. The following table summarizes activity in the liability related to our restructuring initiatives.
(in millions) |
Liability balance as of December 31, 2024 | $ | 122 |
Charges | 26 |
Payments | (36) |
Currency translation | 2 |
Liability balance as of March 31, 2025 | $ | 114 |
Substantially all of our restructuring liabilities as of March 31, 2025 relate to employee termination costs, with the remaining liabilities attributable to contract termination costs. Substantially all of the cash payments for those liabilities are expected to be disbursed by the end of 2025.

X
- References No definition available. + Details
Name: | us-gaap_RestructuringAndRelatedActivitiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 5.P.4.e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/420/tableOfContent Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1 + Details
Name: | us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration